Doxycycline Injection, Powder, Lyophilized, For Solution
Product Images NDC 83634-111

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Doxycycline (NDC 83634-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avenacy Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Dox0d 0000 01)

Package Label – Principal Display Panel – Vial Label (Dox0d 0000 01)
Doxycycline for Injection, USP 100 mg per vial label for lyophilized powder for intravenous infusion, emphasizing single-dose vial and dilution requirement after reconstitution. The label warns to protect solution from direct sunlight, lists inactive ingredients, storage conditions at 20° to 25°C, and states it is manufactured for Avenacy Inc., Schaumburg, IL, made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.